Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Among authors: jacobs ia. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.
Biosimilars: Practical Considerations for Pharmacists.
Stevenson JG, Popovian R, Jacobs I, Hurst S, Shane LG. Stevenson JG, et al. Ann Pharmacother. 2017 Jul;51(7):590-602. doi: 10.1177/1060028017690743. Epub 2017 Feb 8. Ann Pharmacother. 2017. PMID: 28176529 Review.
Considerations in the early development of biosimilar products.
Li EC, Abbas R, Jacobs IA, Yin D. Li EC, et al. Among authors: jacobs ia. Drug Discov Today. 2015 May;20 Suppl 2:1-9. doi: 10.1016/j.drudis.2014.12.017. Epub 2015 Jan 6. Drug Discov Today. 2015. PMID: 25572407 Review.
Development of biosimilars in an era of oncologic drug shortages.
Li E, Subramanian J, Anderson S, Thomas D, McKinley J, Jacobs IA. Li E, et al. Among authors: jacobs ia. Drug Des Devel Ther. 2015 Jun 24;9:3247-55. doi: 10.2147/DDDT.S75219. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26150698 Free PMC article. Review.
Biosimilars in oncology: from development to clinical practice.
Rak Tkaczuk KH, Jacobs IA. Rak Tkaczuk KH, et al. Among authors: jacobs ia. Semin Oncol. 2014 Apr;41 Suppl 3:S3-S12. doi: 10.1053/j.seminoncol.2014.03.008. Epub 2014 Mar 13. Semin Oncol. 2014. PMID: 24767633 Free article. Review.
Biosimilar safety considerations in clinical practice.
Choy E, Jacobs IA. Choy E, et al. Among authors: jacobs ia. Semin Oncol. 2014 Feb;41 Suppl 1:S3-14. doi: 10.1053/j.seminoncol.2013.12.001. Epub 2013 Dec 6. Semin Oncol. 2014. PMID: 24560025
Biosimilars: Extrapolation for oncology.
Curigliano G, O'Connor DP, Rosenberg JA, Jacobs I. Curigliano G, et al. Crit Rev Oncol Hematol. 2016 Aug;104:131-7. doi: 10.1016/j.critrevonc.2016.06.002. Epub 2016 Jun 15. Crit Rev Oncol Hematol. 2016. PMID: 27354233 Free article. Review.
95 results